CHIPping Away at the Pathogenesis of Heart Failure

Peter Libby¹, Siddhartha Jaiswal², Amy E Lin^{3

4}, Benjamin L Ebert⁵

Affiliations

¹ Division of Cardiovascular, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Pathology and Program in Immunology, Stanford University, Stanford, California.
³ Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁵ Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Comment

Peter Libby et al. JAMA Cardiol. 2019.

. 2019 Jan 1;4(1):5-6.

doi: 10.1001/jamacardio.2018.4039.

Peter Libby¹, Siddhartha Jaiswal², Amy E Lin^{3

4}, Benjamin L Ebert⁵

¹ Division of Cardiovascular, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Pathology and Program in Immunology, Stanford University, Stanford, California.
³ Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁵ Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, Schmid T, Brüne B, Wagner S, Serve H, Hoffmann J, Seeger F, Dimmeler S, Zeiher AM, Rieger MA. Dorsheimer L, et al. JAMA Cardiol. 2019 Jan 1;4(1):25-33. doi: 10.1001/jamacardio.2018.3965. JAMA Cardiol. 2019. PMID: 30566180 Free PMC article. Clinical Trial.